Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Robert J. Tokarski"'
Autor:
Yosra A. Helmy, Dipak Kathayat, Loic Deblais, Vishal Srivastava, Gary Closs, Robert J. Tokarski, Oluwatosin Ayinde, James R. Fuchs, Gireesh Rajashekara
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT Avian pathogenic Escherichia coli (APEC) associated with colibacillosis results in high morbidity and mortality, and severe economic losses to the poultry industry. APEC is a zoonotic pathogen and can infect humans through contaminated poult
Externí odkaz:
https://doaj.org/article/9a256d555ac74e5bbf188b4b8115d7ed
Autor:
M. Shamim Hasan Zahid, Monica M. Johnson, Robert J. Tokarski, II, Abhay R. Satoskar, James R. Fuchs, Eric M. Bachelder, Kristy M. Ainslie
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 10, Iss , Pp 125-132 (2019)
Visceral leishmaniasis (VL) is associated with treatment complications due to the continued growth of resistant parasites toward currently available pathogen-directed therapeutics. To limit the emergence and combat resistant parasites there is a need
Externí odkaz:
https://doaj.org/article/716bfe9e4ea0424e8cf76cbbdedd1a0b
Autor:
Robert J. Tokarski, Chia M. Sharpe, Andrew C. Huntsman, Brittney K. Mize, Oluwatosin R. Ayinde, Emily H. Stahl, James R. Lerma, Andrew Reed, Bridget Carmichael, Natarajan Muthusamy, John C. Byrd, James R. Fuchs
Publikováno v:
European Journal of Medicinal Chemistry. 254:115342
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5935d83d9ed1c31bc726d20c2d372243
https://doi.org/10.1016/j.ejmech.2023.115342
https://doi.org/10.1016/j.ejmech.2023.115342
Autor:
Eric M. Bachelder, Abhay R. Satoskar, Robert J. Tokarski, Kristy M. Ainslie, James R. Fuchs, M. Shamim Hasan Zahid, Monica M. Johnson
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 10, Iss, Pp 125-132 (2019)
International Journal for Parasitology: Drugs and Drug Resistance
International Journal for Parasitology: Drugs and Drug Resistance
Visceral leishmaniasis (VL) is associated with treatment complications due to the continued growth of resistant parasites toward currently available pathogen-directed therapeutics. To limit the emergence and combat resistant parasites there is a need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9314ffddae463381a3dab05039b4ec57
https://doi.org/10.1016/j.ijpddr.2019.08.004
https://doi.org/10.1016/j.ijpddr.2019.08.004